德布计划将他的战略扩大到难以治疗的肺癌的临床前模型的更大研究,并与临床医生合作,为临床转化做出推动。 Dhruba Deb, Yangfan Wu, Courtney Coker, Tetsuhiro Harimoto, Ruoqi Huang, Tal Danino.Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer.Scientific Reports,...
When the disease is in an advanced stage, biological therapy is sometimes used. What are new colon cancer treatments and how can I access them? Several medicines have been approved for the treatment of colon cancer around the world. Here are some of the latest chemotherapy drugs for colon ...
Cancer therapy: new trendsNo Abstract available for this article.doi:10.1007/BF00391610P. DringsInnere Medizin-Onkologie Thoraxklinik Heidelberg-RohrbachI. GüntherInnere Medizin-Onkologie Thoraxklinik Heidelberg-RohrbachSpringer-VerlagJournal of Cancer Research & Clinical Oncology...
WASHINGTON, June 22 (Xinhua) -- American and Chinese oncologists suggested a potential therapy to freeze cancer cells before kill them where they stand. A study published on Friday in the journal Nature Communications revealed the novel approach that can halt the movement of cancer cells before t...
The best-studied PARPs generate PAR modifications and include PARP1 and the tankyrase PARP5A, both of which are targets for cancer therapy with inhibitors in either clinical trials or preclinical development. There are 15 additional PARPs, most of which modify proteins with MAR, and their biology...
WASHINGTON, May 10 (Xinhua) -- A team of cancer researchers managed to exploit a vulnerability in melanoma that has developed resistance to a targeted therapy, providing a potential new therapeutic strategy to selectively kill the drug-resistant cancer cells. ...
anti-CCR8 antibody for solid tumors; ZL-1201, a CD47-targeting antibody for advanced hematologic malignancies and solid tumors; ZL-1211, a Claudin18.2-specific antibody for gastric and pancreatic cancer; and ZL-2201, a highly selective small-molecule DNA-PK inhibitor for an...
Freddie Bray, head of the cancer surveillance branch at IARC, said, "The impact of this increase will not be felt evenly across countries of different HDI levels. "Those who have the fewest resources to manage their cancer burdens will bear the brunt of the global cancer burden."...
There have been major advances in the immunotherapy of cancer in recent years, including the development of T cell engagers — antibodies engineered to redirect T cells to recognize and kill cancer cells — for the treatment of haematological malignancies. However, the field still faces several chal...
The paper's co-author Shiladitya Sengupta at Brigham and Women's Hospital said, "We can actually see macrophages eating cancer cells," citing confocal microscopy images in the paper that show macrophages engulfing cancer cells. Kulkarni said next steps are to continue testing the new therapy in ...